NGNE
Neurogene Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$21.51
-0.79 ▼ -3.54%
🌙 3월 13일 6:43 PM ET (한국 3/14 07:43)
$21.82
+0.31 ▲ +1.44%
| Index | RUT | P/E | - | EPS (ttm) | -4.43 | Insider Own | 20.22% | Shs Outstand | 0.01B | Perf Week | -2.98% |
| Market Cap | 0.33B | Forward P/E | - | EPS next Y | -19.56% | Insider Trans | -0.15% | Shs Float | 0.01B | Perf Month | 27.35% |
| Enterprise Value | 0.08B | PEG | - | EPS next Q | -1.24 | Inst Own | 95.58% | Short Float | 29.72% | Perf Quarter | 3.61% |
| Income | -0.09B | P/S | - | EPS this Y | -0.93% | Inst Trans | 11.02% | Short Ratio | 21.41 | Perf Half Y | 7.12% |
| Sales | 0.00B | P/B | 1.2 | EPS next 5Y | -9.84% | ROA | -37.67% | Short Interest | 3.67M | Perf YTD | 4.42% |
| Book/sh | 17.97 | P/C | 1.26 | EPS past 3/5Y | -57.13% -10.74% | ROE | -42.25% | 52W High | -42.28% ($37.27) | Perf Year | 28.04% |
| Cash/sh | 17.13 | P/FCF | - | Sales past 3/5Y | - | ROIC | -31.22% | 52W Low | 212.87% ($6.88) | Perf 3Y | 73.47% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 1.47% | Gross Margin | - | Volatility(W/M) | 7.38% 10.03% | Perf 5Y | -90.99% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 1.97 | Perf 10Y | -86.74% |
| Dividend Ex-Date | - | Quick Ratio | 18.37 | EPS Q/Q | 17% | Profit Margin | - | RSI (14) | 53.37 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 18.37 | Sales Q/Q | - | SMA20 | 4.08% ($20.67) | Beta | 1.54 | Target Price | $81 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 11000000 | SMA50 | 12.23% ($19.17) | Rel Volume | 1.51 | Prev Close | $22.3 |
| Employees | 107 | LT Debt/Eq | 0.03 | EPS/Sales Surpr. | 20.76% - | SMA200 | 1.24% ($21.25) | Avg Volume(3M) | 0.17M | Price | $21.51 |
| IPO | 2014/3/7 | Option/Short | Yes/Yes | Trades | 3602 | Volume | 258,988 | Change | -3.54% |
뉴스 로딩 중...